Zimmer, Biomet Sell Off Some U.S. Assets As They Finalize A $14 Bil. Merger

Zimmer Biomet is now the second-largest orthopedic device maker behind Johnson & Johnson now that the merger between the two firms is complete. The companies divested some U.S. knee, elbow and bone cement assets in conjunction with finalized the deal after having sold of some European assets earlier in the year.

More from Archive

More from Medtech Insight